These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35484871)

  • 1. Evaluation of a Pharmacist-Driven Protocol for the Treatment of Opioid-Induced Constipation.
    Tryson AR; Hennessey EK; Crannage AJ
    J Pharm Pract; 2022 Apr; 35(2):218-222. PubMed ID: 35484871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of oral naloxegol vs subcutaneous methylnaltrexone in treatment of opioid-induced constipation in the hospital setting.
    Nero R; Allen B; Hailu K; Noor R; Theiss K
    Am J Health Syst Pharm; 2023 May; 80(Suppl 2):S70-S76. PubMed ID: 36440903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
    Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
    Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-Related Constipation.
    Liu JJ; Brenner DM
    Gastroenterol Clin North Am; 2022 Mar; 51(1):107-121. PubMed ID: 35135657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
    De Giorgio R; Zucco FM; Chiarioni G; Mercadante S; Corazziari ES; Caraceni A; Odetti P; Giusti R; Marinangeli F; Pinto C
    Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
    Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
    Webster L; Chey WD; Tack J; Lappalainen J; Diva U; Sostek M
    Aliment Pharmacol Ther; 2014 Oct; 40(7):771-9. PubMed ID: 25112584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.
    Tobben D; Carpenter S; Kolar R; Merritt T; Young T; Hauser P; Collier T
    Ann Pharmacother; 2024 Jul; 58(7):678-684. PubMed ID: 37881915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opioid-Induced Constipation in Patients with Cancer Pain].
    Aruga E
    Gan To Kagaku Ryoho; 2021 Nov; 48(11):1311-1315. PubMed ID: 34795117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating naloxegol for the treatment of opioid-induced constipation.
    Daniali M; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2020 Jun; 21(8):883-891. PubMed ID: 32129103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-induced constipation: a stepwise treatment algorithm feasibility study.
    Davies AN; Leach C; Butler C; Patel SD; Shorthose K; Batsari K
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e446-e453. PubMed ID: 34348942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
    Streicher JM; Bilsky EJ
    J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K; Halawi H; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Peripheral μ-Opioid Receptor Antagonists for Treating Opioid-Induced Constipation among US Medicare Beneficiaries from 2014 to 2018.
    Premnath N; Sumarsono A; Sedhom R; Johnson DH; Subbiah IM; Dy SM; Gupta A
    J Palliat Med; 2021 Aug; 24(8):1236-1239. PubMed ID: 33872062
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimal treatment of opioid induced constipation in daily clinical practice - an observational study.
    Neefjes ECW; van der Wijngaart H; van der Vorst MJDL; Ten Oever D; van der Vliet HJ; Beeker A; Rhodius CA; van den Berg HP; Berkhof J; Verheul HMW
    BMC Palliat Care; 2019 Mar; 18(1):31. PubMed ID: 30922276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-induced constipation, use of laxatives, and health-related quality of life.
    Christensen HN; Olsson U; From J; Breivik H
    Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Opioid-induced Constipation in Older Adults.
    Horrigan J; Bhumi S; Miller D; Jafri M; Tadros M
    J Clin Gastroenterol; 2023 Jan; 57(1):39-47. PubMed ID: 36504229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripherally acting μ-opioid antagonist for the treatment of opioid-induced constipation: Systematic review and meta-analysis.
    Nishie K; Yamamoto S; Yamaga T; Horigome N; Hanaoka M
    J Gastroenterol Hepatol; 2019 May; 34(5):818-829. PubMed ID: 30597600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review document of the Spanish Association of Neurogastroenterology and Motility on the management of opioid-induced constipation.
    Serra J; Alcedo J; Barber C; Ciriza de Los Ríos C
    Rev Esp Enferm Dig; 2024 Oct; 116(10):546-553. PubMed ID: 38305669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.